Atlas Trials

Castration-Resistant

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Castration-Resistant

RecordFirmDate
64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) (NCT05633160)Clarity Pharmaceuticals Ltd2023-06-15
Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) (NCT04704505)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2022-04-28
PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide. (NCT02922218)Centro Nacional de Investigaciones Oncologicas CARLOS III2016-06-01
PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223. (NCT02925702)Centro Nacional de Investigaciones Oncologicas CARLOS III2016-02-01
Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer (NCT02200614)Bayer2014-09-12

Track Castration-Resistant automatically

Every clearance here is in the API, with alerts when new ones post.